Generic Name: paclitaxel (PAK li TAK sel)Brand Names: Onxol, Taxol
Paclitaxel is a cancer medication that interferes with the growth of cancer cells and slows their growth and spread in the body.
Paclitaxel is used to treat breast cancer, lung cancer, and ovarian cancer. It is also used to treat AIDS-related Kaposi's sarcoma.
Paclitaxel may also be used for other purposes not listed in this medication guide.
Before you receive paclitaxel, tell your doctor if you have liver disease, heart disease, or a severely weak immune system.
Paclitaxel can lower blood cells that help your body fight infections. This can make it easier for you to bleed from an injury or get sick from being around others who are ill. To be sure your blood cells do not get too low, your blood will need to be tested on a regular basis. Do not miss any scheduled appointments.There are many other medicines that can interact with paclitaxel. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor. Keep a list with you of all the medicines you use and show this list to any doctor or other healthcare provider who treats you.
Before you receive paclitaxel, tell your doctor if you are allergic to any drugs, or if you have:
heart disease; or
a severely weak immune system.
If you have any of these conditions, you may need a dose adjustment or special tests to safely receive paclitaxel.FDA pregnancy category D. This medication can cause harm to an unborn baby. Do not receive paclitaxel without telling your doctor if you are pregnant. It could harm the unborn baby. Use effective birth control, and tell your doctor if you become pregnant during treatment. It is not known whether paclitaxel passes into breast milk or if it could harm a nursing baby. Do not receive this medication without telling your doctor if you are breast-feeding a baby.
Paclitaxel is given as an injection through a needle placed into a vein. You will receive this injection in a clinic or hospital setting. The medicine must be given slowly through an IV infusion, and can take up to 24 hours to complete.
Paclitaxel is usually given every 3 weeks. Follow your doctor's instructions.
Before your injection, you may be given other medications to help prevent a serious allergic reaction to paclitaxel.Tell your caregivers if you feel any burning, pain, or swelling around the IV needle when the medicine is injected.
If any of this medication gets on your skin, wash the area with soap and warm water right away.Your breathing, blood pressure, oxygen levels, and other vital signs will be watched closely while you are receiving paclitaxel.
Your heart rate may also be monitored through electrocardiograph or ECG (sometimes called an EKG). This machine measures electrical activity of the heart.
Paclitaxel can lower blood cells that help your body fight infections. This can make it easier for you to bleed from an injury or get sick from being around others who are ill. To be sure your blood cells do not get too low, your blood will need to be tested on a regular basis. Do not miss any scheduled appointments.
Contact your doctor if you miss an appointment for your paclitaxel injection.
Overdose symptoms may include numbness or tingling, fever, chills, mouth sores, unusual bleeding or weakness, or any signs of infection.
Follow your doctor's instructions about any restrictions on food, beverages, or activity while you are being treated with paclitaxel.
Avoid being near people who have colds, the flu, or other contagious illnesses. Contact your doctor at once if you develop signs of infection.
slow heart rate;
seizure (black-out or convulsions);
pale skin, easy bruising or bleeding, unusual weakness;
fever, chills, body aches, flu symptoms;
white patches or sores inside your mouth or on your lips;
numbness, tingling, or burning pain in your hands or feet;
increased blood pressure (severe headache, blurred vision, buzzing in your ears, anxiety, confusion, chest pain, shortness of breath, uneven heartbeats); or
warmth or redness under your skin.
Less serious side effects may include:
pain, swelling, redness, or skin color changes where the medicine was injected;
joint or muscle pain;
mild nausea, vomiting, diarrhea; or
This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.
Usual Adult Dose for Ovarian Cancer:
For previously untreated patients with cancer of the ovary:175 mg/m2 intravenously over 3 hours every 3 weeks followed by cisplatin or 135 mg/m2 intravenously over 24 hours every 3 weeks followed by cisplatinFor patients previously treated for cancer of the ovary:175 mg/m2 intravenously over 3 hours every 3 weeks or 135 mg/m2 intravenously over 3 hours every 3 weeks
Usual Adult Dose for Kaposi's Sarcoma:
For patients with AIDS-Related Kaposi's Sarcoma:135 mg/m2 intravenously over 3 hours every 3 weeks or100 mg/m2 intravenously over 3 hours every 2 weeksNote: In patients with advanced HIV disease:1) reduce the dose of dexamethasone as one of the three premedication drugs to 10 mg (instead of 20 mg orally)2) Initiate or repeat treatment with paclitaxel only if the neutrophil count is at least 1000 cells/mm33) Reduce the dose of subsequent courses of paclitaxel by 20% for patients who experience severe neutropenia (a neutrophi count <500 cells/mm3 for a week or longer)4) Initiate concomitant hematopoietic growth factor (G-CSF) as clinically indicated.
Usual Adult Dose for Breast Cancer -- Adjuvant:
For adjuvant treatment of node-positive:175 mg/m2 intravenously over 3 hours every 3 weeks for four courses administered sequentially to doxorubicin-containing chemotherapy.
Usual Adult Dose for Breast Cancer:
After failure of initial chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy:175 mg/m2 intravenously over 3 hours every 3 weeks
Usual Adult Dose for Non-Small Cell Lung Cancer:
135 mg/m2 intravenously over 24 hours followed by cisplatin every 3 weeks
Usual Pediatric Dose for Wilms' Tumor:
Recurrent Wilms' tumor: 250-350 mg/m2/dose over 24 hours every 3 weeks